Remove 2028 Remove Clinic Remove Spine
article thumbnail

Amber Implants Announces Successful One-Year Follow-Up Data in First-in-Human Clinical Trial of VCFix® Spinal System

OrthoSpineNews

Notably, no device-related adverse events were reported in any patient at the one-year follow-up, underscoring the strong safety profile and promising clinical potential of VCFix. In addition, significant improvements in key clinical performance outcomes were observed, regardless of cement augmentation. ” said Prof.

Clinic 52
article thumbnail

Polymethyl Methacrylate (PMMA) Bone Cements Market Report 2024: Innovations in Antibiotic-Infused PMMA Bone Cements Accelerate Adoption, Boosting Orthopedic Market Demand

OrthoSpineNews

billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. Markets Covered: By Type: Low Viscosity Cements; Medium Viscosity Cements; High Viscosity Cements By Application: Joint; Vertebral; Other Applications By End-Use: Hospitals; Ambulatory Surgical Centers; Orthopedic Clinics Key Attributes: Report Attribute Details No.

Joints 52
article thumbnail

ATEC Announces Proposed Convertible Senior Notes Offering

OrthoSpineNews

About ATEC ATEC, through its wholly owned subsidiaries, Alphatec Spine, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction. ATECs vision is to become the Standard Bearer in Spine. CARLSBAD, Calif., EOS imaging S.A.S. and SafeOp Surgical, Inc.,